Inventor

PINKSTAFF JASON

US26 patents

⚠️ This page may combine multiple inventors who share the name “PINKSTAFF JASON”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PINKSTAFF JASON

AMBRX INC

Modified FGF-21 polypeptides and their uses

Methods of making FGF-21 mutants comprising non-naturally encoded phenylalanine derivatives

Therapeutic uses of modified relaxin polypeptides

Nucleic acids encoding modified FGF-21 polypeptides comprising non-naturally occurring amino acids

Therapeutic uses of modified relaxin polypeptides

Modified FGF-21 polypeptides comprising non-naturally occurring amino acids

Methods of treatment using modified FGF-21 polypeptides comprising non-naturally occurring amino acids

Nucleic acids encoding modified relaxin polypeptides

Methods of treatment using modified relaxin polypeptides comprising a non-naturally encoded amino acid

Modified relaxin polypeptides comprising a non-naturally encoded amino acid in the A chain

Method of treating heart failure with modified relaxin polypeptides

Modified FGF-21 polypeptides and their uses

Modified FGF-21 polypeptides comprising non-naturally encoding amino acids and their uses

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

Modified FGF-21 polypeptides with non-naturally encoded amino acids

Modified relaxin polypeptides and their uses

Nucleic acids encoding modified relaxin polypeptides

Methods of treating heart failure and fibrotic disorders using modified relaxin polypeptides

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives

Anti-CD70 antibody drug conjugates

Anti-CD70 antibody drug conjugates

KRAYNOV VADIM

Relaxin polypeptides comprising non-naturally encoded amino acids

Modified interferon beta polypeptides and their uses

Modified interferon beta polypeptides and their uses

Modified leptin polypeptides and their uses

MIAO ZHENWEI

Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives